Trials / Completed
CompletedNCT00564941
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 309 (estimated)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of deferasirox in transfusion dependent Myelodysplastic Syndrome, Beta-thalassaemia major patients with chronic iron overload
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | deferasirox |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2007-11-29
- Last updated
- 2017-02-24
Locations
4 sites across 1 country: Hungary
Source: ClinicalTrials.gov record NCT00564941. Inclusion in this directory is not an endorsement.